Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

(APhA) Pharmacy-Based Cardiovascular Disease Risk Management Certificate Program


                                                                                

February 16, 2018

8:00am-5:00pm

 

 

APhA’s Pharmacy-Based Cardiovascular Disease Risk Management is an innovative and interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.

 

The goals of this program are to: 

  • Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
  • Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
  • Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
  • Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
  • Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.

 

Certificate Training Program Components: The activity is conducted in two parts: a web-based self-study and a live training seminar.

  • The self-study modules will focus on these core areas:  
    • Module 1. Cardiovascular Disease Risk Assessment — Assessment of factors that put patients at an increased risk for cardiovascular disease.
    • Module 2. Managing Dyslipidenia — Review of pathophysiology, explanation of the recommended approach to treatment, and extensive discussion of pharmacologic options for the management of dyslipidemia.
    • Module 3. Managing Hypertension — Review of pathophysiology, explanation of the recommended approach to treatment, and extensive discussion of pharmacologic options for the management of hypertension.
    • Module 4. Lifestyle Modifications and Risk Factor Management —Discussion of recommended dietary interventions, physical activity, weight reduction, and smoking cessation.
    • Module 5. The Pharmacist’s Role in Cardiovascular Disease Prevention and Management — Explanation of ongoing patient monitoring techniques and communication with prescribers to optimize patient self-management (including adherence and behavior change counseling).
  • The live seminar will focus on these core areas:
    • A case-based approach to cardiovascular disease risk assessment and treatment decisions, managing special situations, treating hypertension in a patient with diabetes, and lifestyle modifications and motivational interviewing.
    • Skills assessments on blood pressure measurement technique and motivational interviewing. Participants will be conducting blood pressure assessments on other participants.
    • A discussion regarding the role of the pharmacist and existing business models for cardiovascular disease risk management services.

Seminar Agenda: 

  • 7:30AM: Registation
  • 8:00AM-12:00PM
    • Welcome and Introductions
    • Cardiovascular Disease Risk Assessment and Treatment Decisions
    • Aspirin for Primary Prevention of ASCVD Events
    • Break (15 min)
    • Special Considerations for Management of Hypertension and Lipids in Patients with Chronic Kidney Disease or Advanced Age
    • Treatment Decisions for Patients with Borderline Risk
    • Managing Risks of Statin Therapy
    • Hospital Readmissions
    • Lifestyle Modifications
  • Lunch and Networking (30 minutes)- Pizza and water will be provided-feel free to bring your own food and snacks
  • 12:30PM-5:00PM
    • Motivational Interviewing
    • Motivational Interviewing Activity
    • Patient Assessment Skills
    • Blood Pressure Measurement Practice
    • Break (15 min)
    • Business Considerations and Practice Models
    • Transitions of Care Patient Case
    • Take Home Points, Questions, and Final Instructions
    • Adjournment

PROGRAM FEE

BY PARTICIPANT

UNTIL 1/16/2018

Use Code Below

AFTER 1/16/2018

 

  • AzPA Member Pharmacist

$350

$400

  • Non-Member Pharmacist

$450

$500

  • AzPA Member Student

$250

$300

  • Non-Member Student

$300

$350

 

 

 

 

 

 

 

 

 

 

 

 

Use Coupon Code: Cardio216 for the early bird rates

 

Refund Policy:

Refund and/or cancellation requests must be made in writing to the Arizona Pharmacy Association office. A cancellation request must be made at last fourteen calendar days prior to the scheduled program and will require a $175.00 fee. No refunds will be issued for cancellation requests made less than fourteen calendar days prior to the scheduled program. You must submit a written request to cancel by email, fax, or standard mail and confirm that AzPA has received the request. AzPA reserves the right to cancel any activity due to insufficient pre-registration or as determined by the Executive Director or CE Administrator. In this case, all individuals pre-registered are notified and issued a fill refund. Registration fees cannot be re-allocated due to the multiple steps involved with processing CE Credits. Refund checks will be mailed fourteen business days after the conclusion of the meeting, if approved. For more information about refunds and/or cancellation requests please contact the Operations Director.

 

Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements:

  • Initial release date: 01/01/2018
  • Expiration date:  08/31/2018
  • Activity Type:  Practice-based
  • Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
  • Target Audience:  Pharmacists in all practice settings 
  • Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs). ACPE Universal Activity Number: 0202-9999-18-106-H01-P
  • Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU). ACPE Universal Activity Number: 0202-9999-18-107-L01-P

Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at www.nabp.net. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com

 

Activity Completion Requirements:

A Certificate of Achievement is awarded to participants who successfully complete all activity requirements, which include a pre-test, the self-study activity, the self-study assessment, the live training seminar, and the final assessment. Successful completion is defined as completing the pre-test, a self-study assessment score of 70% or higher, attendance at the live seminar, a final assessment score of 70%, and completion of the activity evaluation.

Activity Requirements -  Course material and exams will be accessed online - In order to participate in this activity, registrants must have access to a computer with minimum system requirements:  Internet connectivity with current version of internet browsers, such as Chrome, Firefox, Safari, or Internet Explorer (V8 and above); Adobe Acrobat Reader, Flash Player 8 or higher, Windows 95, Pentium 3 or equivalent processor, 64 MB of free memory (not 64 MB total), and Audio: Sound card and speakers or earphones.  For full technology requirements, please visit http://www.pharmacist.com/pharmacy-based-immunization-delivery

 

APhA’s Pharmacy-Based Cardiovascular Disease Risk Management  was developed by the American Pharmacists Association.   The American Pharmacists Association and the Arizona Pharmacy Association are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Date: Feb 16, 2018 08:00 AM - 05:00 AM

Registration closes on Feb 14, 2018 12:00 AM

Target Audience(s)

  • Pharmacists
  • Student

Joint Provider

APhA

 

 

 

   

Speaker(s)/Author(s)

Lindsay E. Davis picture

Lindsay E. Davis, PharmD, BCPS, FAzPA
Associate Professor, Midwestern University College of Pharmacy


Brief Bio : Lindsay E. Davis, Pharm.D., BCPS, FAzPA Lindsay E. Davis is an Associate Professor at Midwestern University College of Pharmacy (CPG) in the Department of Pharmacy Practice. Dr. Davis received her Doctor of Pharmacy degree at The University of Arizona in 2003 and completed her residency training at The Phoenix VA Medical Center in adult acute care in 2009-2010. Dr. Davis has practiced in both hospital and retail pharmacy. Her current appointment with Midwestern University allows her to precept students in advanced pharmacy practice experiences at Banner Estrella Medical Center and Cardiac Solutions. Dr. Davis also serves on the Banner Estrella PGY1 Pharmacy Practice Residency Advisory Committee and offers a residency rotation in internal medicine with a focus on cardiovascular medicine. Her current interests are focused in internal medicine, cardiology, anticoagulation, student mentorship and professional development. Dr. Davis completed the American College of Clinical Pharmacy Academy’s Teaching and Learning Certificate Program in 2012 and led the efforts to develop CPG’s Clinician Educators Program with the inaugural offering in 2013. She has been honored to receive the Mentor of the Year Award from CPG 2011, Teacher of the Year Award from CPG Classes of 2013 and 2014 and the Outstanding Educator Award from CPG Class of 2015. She was recognized with the Upsher-Smith Innovative Practice Award from the Arizona Pharmacy Association in 2012.

MaryJo Zunic, PharmD, MHA, BCACP, PhC
Pharmacist Clinician, Indian Health Services


Brief Bio : Dr. Zunic graduated from the University of Arizona in 2000 and completed a general pharmacy practice residency at Phoenix Indian Medical Center in 2001. She has continued to develop her clinical skills by completing certificate courses in diabetes, lipid management, hypertension, anticoagulation and immunization prescribing. She earned her BCPS in 2007 and since then has earned her BCACP in 2015. Her pharmacist clinician license was granted in 2005 from the state of New Mexico. Most of her practice has varied from working in the outpatient pharmacy environment at various Indian Health Service sites to also supervising and working as a Pharmacist Clinician within the Healthy Heart Project at Albuquerque Indian Health Center. She now works full time on a patient care team within the Albuquerque Indian Health Service as a pharmacist clinician. In addition to her clinical skills development, she has taken leadership courses with ASHP and completed her MHA with Simmons College in 2013. She was tasked by her clinic to work as a Quality and Performance Improvement officer in 2012, on a one-year assignment to get the organization ready for the AAAHC re-accreditation cycle. She serves in various leadership capacities within her clinic and also nationally on the PHS Pharmacy Professional Advisory Committee. Dr. Zunic enjoys teaching and has done presentations at the National Arizona Pharmacy Association meetings on diabetes care and also within the Indian Health Service Southwest Regional Pharmacy Continuing Education Meeting on various topics such as diabetes care, vitamin D, lipid management, and utilizing quality and performance improvement tools to advance your practice. She has also served as faculty with the Pharmacy Practice Training Program within the Indian Health Service for 8 years now.
Date: 02/16/18
Time: 08:00 AM - 05:00 PM